Evidence map›Paper›PMID 39421608›Full record

ArticleFrontiers in chemistry2024

Cheng Yu, Linan Hu, Qilin Yu, Yulu Ren, Minping Zhang, Lujing Gao, Shiyi Lyu, Junli Wang, Enhua Xiao, Zhu Chen and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cheng YuDepartment of Radiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Linan HuDepartment of Radiology, Zhuzhou Central Hospital, Zhuzhou, Hunan, China.
Qilin YuDepartment of Radiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yulu RenDepartment of Radiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Minping ZhangDepartment of Radiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Lujing GaoDepartment of Radiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Shiyi LyuDepartment of Radiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Junli WangDepartment of Ultrasound, The Air Force Hospital of Southern Theater Command, Guangzhou, Guangdong, China.
Enhua XiaoDepartment of Radiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zhu ChenDepartment of Radiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Quanliang ShangDepartment of Radiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Pengfei XuDepartment of Nuclear Medicine, Weifang People's Hospital, Shandong Second Medical University, Weifang, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eliciting anti-tumor immune responses and improving the tumor microenvironment crucial for boosting the effectiveness of anti-PD-1 immunotherapy. Tumor-associated macrophages (TAMs), the primary types of immune cells infiltrating tumors, play a critical role in the formation of an immunosuppressive microenvironment. In this study, we constructed a novel Evans Blue (EB)-based

Indexed as

albumin nanoparticleCDTimmunotherapyNIR-II imagingtumor-associated macrophage

Identifiers

PMID39421608
PMCPMC11484263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.